INTRAVENOUS THROMBOLYSIS AND CLOT RETRIEVAL FOLLOWING REVERSAL OF DABIGATRAN WITH IDARUCIZUMAB

被引:1
|
作者
Tse, Dominic M. Y. [1 ]
Young, Laura [2 ]
Ranta, Anna M. [3 ]
Barber, P. A. [1 ]
机构
[1] Auckland Dist Hlth Board, Dept Neurol, Auckland, New Zealand
[2] Auckland Dist Hlth Board, Dept Haematol, Auckland, New Zealand
[3] Univ Otago, Auckland, New Zealand
来源
关键词
D O I
10.1136/jnnp-2017-316074.7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
7
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Intravenous stroke thrombolysis after reversal of dabigatran effect by idarucizumab: first reported case in Hong Kong
    Lo, W. T.
    Ng, K. F.
    Chan, Simon C. H.
    Kwok, Vivian W. Y.
    Fong, C. S.
    Chan, S. T.
    Wong, Gordon C. K.
    Fong, W. C.
    HONG KONG MEDICAL JOURNAL, 2018, 24 (01) : 81 - 83
  • [22] Reversal of Dabigatran with Idarucizumab
    Sodha, Neel R.
    Sellke, Frank W.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (08) : 889 - 893
  • [23] Idarucizumab for the Reversal of Dabigatran
    Gottlieb, Michael
    Khishfe, Basem
    ANNALS OF EMERGENCY MEDICINE, 2017, 69 (05) : 554 - 558
  • [24] Idarucizumab for Dabigatran Reversal
    Pollack, Charles V., Jr.
    Reilly, Paul A.
    Eikelboom, John
    Glund, Stephan
    Verhamme, Peter
    Bernstein, Richard A.
    Dubiel, Robert
    Huisman, Menno V.
    Hylek, Elaine M.
    Kamphuisen, Pieter W.
    Kreuzer, Jrg
    Levy, Jerrold H.
    Sellke, Frank W.
    Stangier, Joachim
    Steiner, Thorsten
    Wang, Bushi
    Kam, Chak-Wah
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (06): : 511 - 520
  • [25] Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis
    Satoshi Hosoki
    Masahito Takagi
    Hiroshi Yamagami
    Daisuke Ando
    Kazunori Toyoda
    Masatoshi Koga
    Journal of Neurology, 2018, 265 : 2451 - 2453
  • [26] Paradoxical elevation of plasma dabigatran after reversal with idarucizumab in stroke thrombolysis
    Hosoki, Satoshi
    Takagi, Masahito
    Yamagami, Hiroshi
    Ando, Daisuke
    Toyoda, Kazunori
    Koga, Masatoshi
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2451 - 2453
  • [27] Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model
    Akman, N.
    Braunschweig, T.
    Honickel, M.
    Schuett, K.
    Schoechl, H.
    Stoppe, C.
    Rossaint, R.
    Grottke, O.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 120 (05) : 978 - 987
  • [28] Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan
    Fang, Chen-Wen
    Tsai, Yi-Te
    Chou, Ping-Chen
    Chen, Hsi-Ming
    Lu, Chien-Ming
    Tsao, Chen-Rong
    Chen, Chih-Lin
    Sun, Mu-Chien
    Shih, Yu-Song
    Hsieh, Cheng-Yang
    Chen, Lu-An
    Chen, Po-Lin
    Yeh, Jung-Tze
    Li, Yi-Heng
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (03): : 815 - 820
  • [29] Idarucizumab The Antidote for Reversal of Dabigatran
    Eikelboom, John W.
    Quinlan, Daniel J.
    van Ryn, Joanne
    Weitz, Jeffrey I.
    CIRCULATION, 2015, 132 (25) : 2412 - 2422
  • [30] Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab
    Loh, Chee Hoou
    Herkes, Geoffrey
    BMJ CASE REPORTS, 2019, 12 (05)